Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference
Rhea-AI Summary
Exagen Inc. (Nasdaq: XGN), a leading autoimmune testing solutions provider, has announced its participation in the 2024 Cantor Global Healthcare Conference. The event is scheduled for September 17-19, 2024, at the InterContinental Barclay Hotel in New York City.
Key highlights:
- John Aballi, President and CEO, and Jeff Black, CFO, will represent Exagen
- They will participate in a fireside chat on Wednesday, September 18th, at 9:45 AM ET
- The conference provides a platform for healthcare companies to showcase their innovations and connect with investors
This participation underscores Exagen's commitment to engaging with the investment community and sharing insights into its autoimmune testing solutions.
Positive
- None.
Negative
- None.
News Market Reaction – XGN
In the trading session that priced this news, XGN gained 15.93%, reflecting a significant positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CARLSBAD, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the 2024 Cantor Global Healthcare Conference, which takes place September 17-19, 2024, at the InterContinental Barclay Hotel in New York City. John Aballi, Exagen’s President and Chief Executive Officer and Jeff Black, Exagen’s Chief Financial Officer, will participate in a fireside chat on Wednesday, September 18th, at 9:45 AM ET.
About Exagen Inc.
Exagen is a leading provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision making with the goal of improving patients’ clinical outcomes. Exagen is located in San Diego County, California.
For more information, please visit Exagen.com or follow @ExagenInc on X (formerly known as Twitter).
Contact:
Ryan Douglas
Exagen Inc.
ir@exagen.com
760.560.1525
